TickerStat.comwe like data

COSCIENS Biopharma Inc. (CSCIF)

Price$5.35Cached quote
CSCIFOTC
Loading local price history

Financial charts

Revenue

Net income

Total cash / debt

CashTotal debt

Financial statements

11 annual periodsNewest to oldest
20252024202320222021202020192018201720162015
Revenue$7.5M$9.6M$7.1M$14.6M$5.3M$3.7M$532,000$26.9M$923,000$911,000$545,000
Gross profit$2.6M$4.7M$2.9M$8.6M$5.2M$1.3M$122,000$24.8M$923,000$911,000—
Gross margin35.30%49.33%41.13%58.72%98.29%36.56%22.93%92.17%100.00%100.00%—
Research & development$3.0M$8.3M$2.0M$1.4M$6.6M$1.5M$1.8M$2.9M$10.7M$16.5M$17.2M
Operating expenses$13.3M$23.0M$7.6M$4.2M$13.9M$9.4M$10.8M$17.0M$24.0M$30.4M$35.4M
Operating income−$10.7M−$18.3M−$4.6M$4.3M−$8.7M−$5.7M−$10.2M$9.8M−$23.1M−$29.5M−$34.9M
Operating margin−142.45%−190.67%−64.80%29.65%−164.85%−156.24%−1,925.19%36.61%−2,499.89%−3,235.57%−6,400.73%
EBITDA−$9.5M−$16.7M−$3.2M$5.8M−$8.5M−$5.5M−$9.9M$9.9M−$22.9M−$29.3M−$34.6M
EBITDA margin−126.61%−173.91%−44.60%39.72%−162.11%−149.89%−1,865.98%36.84%−2,484.94%−3,214.16%−6,351.01%
Net income−$10.4M−$15.3M−$3.5M$3.4M−$8.4M−$5.1M−$6.0M$4.2M−$16.8M−$25.0M−$50.1M
Net profit margin−138.14%−159.68%−48.79%23.66%−159.09%−140.14%−1,135.71%15.58%−1,819.72%−2,739.74%−9,200.55%
Basic EPSper basic share-$3.27-$5.93-$1.89$1.87-$1.82-$3.11-$0.35$0.25-$1.12-$2.41-$18.14
Diluted EPSper diluted share-$3.27-$5.93-$1.89$1.86-$1.82-$3.11-$0.35$0.24-$1.12-$2.41-$18.14
Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about CSCIF yet. Start the conversation.

Write the first post